Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Centogene N.V. (NQ: CNTG )

1.040 -0.010 (-0.95%)
Streaming Delayed Price Updated: 2:53 PM EDT, Oct 3, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 21,671
Open 1.040
Bid (Size) 1.050 (3)
Ask (Size) 1.070 (1)
Prev. Close 1.050
Today's Range 1.040 - 1.050
52wk Range 0.6100 - 2.520
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
CENTOGENE to Present at H.C. Wainwright 25th Annual Global Investment Conference
From Centogene NV
Via GlobeNewswire
CENTOGENE Reports First Half 2023 Financial Results
Strong Revenues and Steady Growth in Both Diagnostics and Pharma Segments Drive Sustainable Financial Performance 
From Centogene NV
Via GlobeNewswire

Performance

YTD
+16.85%
+16.85%
1 Month
-7.14%
-7.14%
3 Month
-28.77%
-28.77%
6 Month
+60.05%
+60.05%
1 Year
-18.75%
-18.75%

More News

Read More
CENTOGENE Announces Publication Establishing Lyso-Gb1 as a Predictive Biomarker for Gaucher Disease Patients
From Centogene NV
Via GlobeNewswire
Analyst Expectations for Centogene's Future
Via Benzinga
The Latest Analyst Ratings for Centogene
Via Benzinga
HC Wainwright & Co. Maintains Buy Rating for Centogene: Here's What You Need To Know
Via Benzinga
CENTOGENE Receives Nasdaq Non-Compliance Notification Regarding Minimum Market Value of Publicly Held Shares Deficiency
From Centogene NV
Via GlobeNewswire
CENTOGENE to Participate in Upcoming Conferences in August
From Centogene NV
Via GlobeNewswire
CENTOGENE Regains Compliance With Nasdaq Listing Requirements
From Centogene NV
Via GlobeNewswire
CENTOGENE Biodatabank Reveals Unique Genetic Variants in World's Largest Niemann-Pick Type C1 Disease Cohort
From Centogene NV
Via GlobeNewswire
CENTOGENE Announces Approval of All Resolutions Tabled at 2023 Annual General Meeting
From Centogene NV
Via GlobeNewswire
Why CorMedix Are Trading Lower By 22%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Why Franklin Covey Shares Are Trading Higher By 25%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
Why Theriva Biologics Are Trading Higher By Over 76%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
Nasdaq Jumps Over 200 Points; TD Synnex Posts Downbeat Results
Via Benzinga
Why Walgreens Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Dow Surges Over 100 Points; Walgreens Lowers Earnings Forecast
Via Benzinga
Why Centogene (CNTG) Stock Is Roaring Higher Tuesday
Via Benzinga
CENTOGENE and Lifera, a Biopharma Company Owned by the PIF, Enter Strategic Collaboration – Forming Saudi Arabian Joint Venture to Increase Access to Leading Data-Driven Multiomic Testing and Securing CENTOGENE $30 Million Investment
From Centogene NV
Via GlobeNewswire
CENTOGENE Receives Nasdaq Notification Regarding Minimum Market Value of Publicly Held Shares Deficiency
From Centogene NV
Via GlobeNewswire
CENTOGENE Reports Full Year 2022 Financial Results
From Centogene NV
Via GlobeNewswire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
CENTOGENE to Participate in Upcoming Conferences in May
From Centogene NV
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.